Perioperative management of esophageal cancer

Nature Reviews Clinical Oncology

Volumn 7, Issue 4, 2010, Pages 231-238

  Okines, Alicia ^a   Sharma, Bhupinder ^a   Cunningham, David ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CISPLATIN; EPIRUBICIN; ETOPOSIDE; FLUOROPYRIMIDINE; FLUOROURACIL; FOLINIC ACID; PACLITAXEL;

CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DYSPHAGIA; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; GASTROINTESTINAL HEMORRHAGE; HUMAN; INTERMETHOD COMPARISON; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TREATMENT RESPONSE;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; CISPLATIN; ESOPHAGEAL NEOPLASMS; HUMANS; PROGNOSIS; PYRIMIDINES; TREATMENT OUTCOME;

EID: 77950517221     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2010.20     Document Type: Review

References (35)

1. Parkin, D. M., Bray, F., Ferlay, J. & Pisani, P. Global cancer statistics, 202. CA Cancer J. Clin. 55, 74-108 (2005).
2. vizcaino, A. P., Moreno, v., Lambert, R. & Parkin, D. M. Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995. Int. J. Cancer 99, 860-868 (2002). (Pubitemid 34575705)
3. Kubo, A. & Corley, D. A. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol. Biomarkers Prev. 15, 872-878 (2006). (Pubitemid 43823511)
4. walsh, T. N. et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N. Engl. J. Med. 335, 462-467 (1996). (Pubitemid 26269945)
5. Medical Research Council Oesophageal Cancer working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 359, 1727-1733 (2002). (Pubitemid 34607086)
6. Cunningham, D. et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N. Engl. J. Med. 355, 11-20 (2006).
7. Gebski, v. et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesphageal carcinoma: a meta-analysis. Lancet Oncol. 8, 226-234 (2007). (Pubitemid 46291702)
8. Bedenne, L. et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J. Clin. Oncol. 25, 1160-1168 (2007). (Pubitemid 46640561)
9. Stahl, M. et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J. Clin. Oncol. 23, 2310-2317 (2005). (Pubitemid 46218723)
10. Kelsen, D. P. et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N. Engl. J. Med. 339, 1979-1984 (1998).
11. Allum, w. H., Stenning, S. P., Bancewicz, J., Clark, P. I. & Langley, R. e. Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J. Clin. Oncol. 27, 5062-5067 (2009).
12. Tepper, J. et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J. Clin. Oncol. 26, 1086-1092 (2008).
13. Stahl, M. et al. Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J. Clin. Oncol. 27, 851-856 (2009).
14. Burmeister, B. H. et al. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol. 6, 659-668 (2005).
15. Ott, K. et al. Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction. J. Clin. Oncol. 24, 4692-4698 (2006). (Pubitemid 46646244)
16. Lordick, F. et al. PeT to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. Lancet Oncol. 8, 797-805 (2007). (Pubitemid 47308659)
17. Cunningham, D. et al. Capecitabine and oxaliplatin for advanced esophagogastric cancer. N. Engl. J. Med. 358, 36-46 (2008).
18. Bamias, A. et al. Adjuvant chemotherapy for oesophagogastric cancer with epirubicin, cisplatin and infusional 5-fluorouracil (eCF): a Royal Marsden pilot study. Br. J. Cancer 71, 583-586 (1995).
19. Armanios, M. et al. Adjuvant chemotherapy for resected adenocarcinoma of the esophagus, gastro-esophageal junction, and cardia: phase II trial (e8296) of the eastern Cooperative Oncology Group. J. Clin. Oncol. 22, 4495-4499 (2004). (Pubitemid 41185115)
20. Liu, H. C. et al. esophagectomy for locally advanced esophageal cancer, followed by chemoradiotherapy and adjuvant chemotherapy. World J. Gastroenterol. 11, 5367-5372 (2005). (Pubitemid 41410308)
21. Kelsen, D. P. et al. Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. J. Clin. Oncol. 25, 3719-3725 (2007).
22. The Medical Research Council Oesophageal Cancer working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 359, 1727-1733 (2002). (Pubitemid 34607086)
23. Nygaard, K. et al. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J. Surg. 16, 1104-1109 (1992). (Pubitemid 23065529)
24. Bosset, J. F. et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N. Engl. J. Med. 337, 161-167 (1997). (Pubitemid 27306287)
25. Lee, J. L. et al. A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma. Ann. Oncol. 15, 947-954 (2004).
26. Le Prise, e. et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 73, 1779-1784 (1994). (Pubitemid 24101950)
27. Urschel, J. D. & vasan, H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am. J. Surg. 185, 538-543 (2003). (Pubitemid 36627845)
28. Fiorica, F. et al. Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut 53, 925-930 (2004). (Pubitemid 38824146)
29. Chiu, P. w. et al. Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: early results from the Chinese University Research Group for esophageal Cancer (CURe). J. Gastrointest. Surg. 9, 794-802 (2005).
30. Borghesi, S., Hawkins, M. A. & Tait, D. Oesophagectomy after definitive chemoradiation in patients with locally advanced oesophageal cancer. Clin. Oncol. (R. Coll. Radiol.) 20, 221-226 (2008).
31. Ando, N. et al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study-JCOG9204. J. Clin. Oncol. 21, 4592-4596 (2003). (Pubitemid 46594032)
32. Zhang, J., Chen, H. Q., Zhang, Y. w. & Xiang, J. Q. Adjuvant chemotherapy in oesophageal cancer: a meta-analysis and experience from the Shanghai Cancer Hospital. J. Int. Med. Res. 36, 875-882 (2008).
33. Zieren, H. U. et al. Adjuvant postoperative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus: a prospective randomized study. World J. Surg. 19, 444-449 (1995).
34. Tachibana, M. et al. Postoperative chemotherapy vs chemoradiotherapy for thoracic esophageal cancer: a prospective randomized clinical trial. Eur. J. Surg. Oncol. 29, 580-587 (2003). (Pubitemid 37121758)
35. Apinop, C., Puttisak, P. & Preecha, N. A prospective study of combined therapy in esophageal cancer. Hepatogastroenterology 41, 391-393 (1994). (Pubitemid 24273251)